Cannabis Use Associated With Improved Outcomes In Bipolar Patients

Comedy_and_tragedy_masks_without_background.svg

MASSACHUSETTS: Cannabis use is associated with an alleviation of clinical symptoms in patients with bipolar disorder, and does not negatively impact cognitive performance, according to clinical trial data published in the journal PLoS One. Investigators with Harvard Medical School, Tufts University, and McLean Hospital in Massachusetts assessed the impact of marijuana use on mood symptomology and cognitive Read the full article…

Thousands Of Peer-Reviewed Studies Specific To Medical Cannabis Have Been Published Over Past Decade

Medical-Science

ISRAEL: The total number of peer-reviewed scientific papers dedicated to cannabis, and the therapeutic use of cannabis in particular, has increased exponentially in recent years, according to data published the journal Population Health Management. Israeli researchers assessed trends in the number of scientific publications specific to cannabis as compared to all scientific publications during the years 2000 to 2017. They reported: Read the full article…

Cannabics Pharmaceuticals Announces Positive Results for Pilot Study on Treatment of Cancer Anorexia-Cachexia Syndrome (CACS)

MMJ reduces opioid use

Preliminary findings showed +80% of patients had increase in appetite and 60% +10% weight increase ISRAEL & MARYLAND: Cannabics Pharmaceuticals, a leader in personalized cannabinoid medicine focused on cancer and its side effects, announced the results of its pilot study to test the efficacy of Cannabics capsules for the treatment of cancer anorexia-cachexia syndrome (CACS) in advanced Read the full article…

MedMen Increases Term Loan Facility to C$100 Million

medmen

CALIFORNIA: MedMen Enterprises announced today that it has closed an additional tranche of its previously announced senior secured term loan with funds managed by Hankey Capital and an affiliate of Stable Road Capital. Pursuant to the terms of the Facility, the principal amount of the loan has been increased by C$5,661,920 to C$99,952,190. The principal amount under Read the full article…

Father of THC Dr. Raphael Mechoulam Keynotes CannX Oct 14-16 In Tel Aviv

Dr Raphael Machoulam

ISRAEL: Dr. Raphael Mechoulam, Professor of Medicinal Chemistry at The Hebrew University of Jerusalem, Israel, and the man credited with first discovering and isolating THC will keynote the 3rd International Medical Cannabis Conference (CannX), October 14-16th in Tel Aviv. Speaking on The Plant Cannabinoids And The Endocannabinoid System — An Overview Of Research Over Five Decades, Dr. Mechoulam will set Read the full article…

Study: Cannabis Inhalation Not Associated With COPD, Other Tobacco-Related Harms

"The long-term respiratory effects of cannabis differ from traditional smoking," authors concluded. "[C]annabis smoking does not appear to be carcinogenic."

UNITED KINGDOM: Cannabis smoke exposure, even long-term, is not positively associated with chronic obstructive pulmonary disease (COPD), lung cancer, or irreversible airway damage, according to a literature review published in the journal Breathe. British researchers reviewed nearly 20 observational studies assessing cannabis inhalation and lung health, involving over 25,000 subjects. Investigators reported that the available literature fails to support Read the full article…

Curaleaf New Jersey Launches State’s First And Only Line Of Strain Specific Pure Cannabis Vape Concentrates

NJ’s leading dispensary increases product offerings after receiving state approval

NEW JERSEY: Curaleaf New Jersey, a provider of state licensed cannabinoid-based products, today launched a new line of natural, terpene rich, strain specific, vaporable cannabis concentrates for patients of its Bellmawr dispensary. The first in New Jersey to manufacture products in this category, Curaleaf continues to set the industry standard by expanding its already-diverse medical cannabis Read the full article…

Study: Cannabis Lozenge Associated With Reduced Opioid Use

Trokie Lozenge

CALIFORNIA: Patients who consume plant-derived cannabis extracts in the form of an oral lozenge report reductions in chronic pain and opioid use, according to clinical data published in the journal Frontiers in Neuroscience. Investigators from the United States, the Netherlands, and Spain assessed the safety and efficacy of the Trokie brand lozenge in a cohort of medical cannabis patients Read the full article…

Fibromyalgia Patients Report Subjective Benefits From Cannabis

Pain relief was reported by 94 percent of cannabis consumers

ISRAEL: Patients suffering from fibromyalgia frequently use cannabis to treat chronic pain and other symptoms of the disease, according to data published in the journal Pain Research and Treatment. Israeli researchers surveyed over 2,700 fibromyalgia patients. Of those who responded to the questionnaire, 84 percent reported consuming cannabis. “Pain relief was reported by 94 percent of cannabis consumers, while 93 percent Read the full article…

Study: Cannabis Leaves Possess Anti-Bacterial Activity Against MRSA

cannabis leaves possess anti-bacterial properties

INDIA: Ethanol-based tinctures containing crushed cannabis leaves provide anti-bacterial effects against methicillin-resistant Staphylococcus aureus (MRSA), according to data published in the Journal of Integrative Medicine. Strains of the MRSA bacterium are often resistant to antibiotic treatment and can be associated with life-threatening infections, such as septic shock and severe pneumonia. A team of researchers from India assessed the antimicrobial Read the full article…